Your trusted source for investing success

Tag: SEC

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.

 “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers

Blue Sky Makes Significant New Uranium-Vanadium Discovery at Amarillo Grande Project, Argentina

Blue Sky Makes Significant New Uranium-Vanadium Discovery at Amarillo Grande Project, Argentina

Blue Sky Uranium(TSXV:BSK) is pleased to report Phase I Extension reverse circulation (RC) drilling results for the Ivana target and the Phase I results from the remainder of the Amarillo Grande uranium-vanadium project, in Rio Negro Province, Argentina (see Map 1: https://www.blueskyuranium.com/assets/news/2017-09-18-nrm1-bsk-g97x6f.pdf ).

At the Ivana target, RC drilling on the eastern flank

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

 “The opening of this

Natcore Technology Announces Private Placement

Natcore Technology Announces Private Placement

Natcore Technology Inc. (TSXV:NXT)  has announced its intent to raise CDN$75,000 via a non-brokered private placement.

The placement involves the sale of up to 500,000 units at a price of CDN$0.15 per unit. Each unit comprises one common share and one share purchase warrant. Each warrant will entitle the holder to purchase

Nano Dimension Partners with CADvision to Distribute Nano Dimension’s 3D Printer in France, Belgium and Switzerland

Nano Dimension Partners with CADvision to Distribute Nano Dimension’s 3D Printer in France, Belgium and Switzerland

Nano Dimension (TASE:NNDM,NASDAQ:NNDM), announced today that its wholly owned subsidiary, Nano Dimension Technologies Ltd., intends to collaborate with CADvision, a leading 3D printing distributor in France, to develop the commercial and service infrastructure to commence sales and support of the DragonFly 2020 3D Printer across France, Belgium and Switzerland.  Nano Dimension and CADvision will

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid-induced respiratory depression, and respiratory insufficiency due to spinal cord injury, announces that the Company’s Chief Executive Officer and Vice Chairman of the Board of Directors, James

DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017

DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that Jeffrey Bacha, president & CEO of the Company, will be presenting at the 19th Annual Rodman & Renshaw Global Investment Conference being held September 10-12, 2017, at the Lotte New York Palace Hotel in New York

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Q BioMed Announces Development Partnership With Sphaera Pharma

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/q-biomed-announces-development-partnership-sphaera-pharma/